Chiara Bosa

534 total citations
16 papers, 241 citations indexed

About

Chiara Bosa is a scholar working on Pathology and Forensic Medicine, Genetics and Neurology. According to data from OpenAlex, Chiara Bosa has authored 16 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 7 papers in Neurology. Recurrent topics in Chiara Bosa's work include Multiple Sclerosis Research Studies (8 papers), Glioma Diagnosis and Treatment (7 papers) and Peripheral Neuropathies and Disorders (4 papers). Chiara Bosa is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Glioma Diagnosis and Treatment (7 papers) and Peripheral Neuropathies and Disorders (4 papers). Chiara Bosa collaborates with scholars based in Italy. Chiara Bosa's co-authors include Riccardo Soffietti, Roberta Rudà, Elisa Trevisan, Luca Bertero, Marco Vercellino, Paola Cavalla, Umberto Ricardi, Anna Castiglione, Chiara Monagheddu and Michela Magistrello and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Environmental Research and Public Health and Journal of Neuroimmunology.

In The Last Decade

Chiara Bosa

15 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Bosa Italy 9 126 76 60 44 43 16 241
Ana Ramos Spain 7 89 0.7× 68 0.9× 87 1.4× 43 1.0× 66 1.5× 13 281
Massimo Napolitano Italy 9 164 1.3× 48 0.6× 82 1.4× 149 3.4× 33 0.8× 16 349
Andrés Cervio Argentina 10 76 0.6× 34 0.4× 77 1.3× 36 0.8× 14 0.3× 48 297
Christopher Dardis United States 11 136 1.1× 26 0.3× 57 0.9× 103 2.3× 24 0.6× 27 321
Danielle Golub United States 9 136 1.1× 26 0.3× 65 1.1× 63 1.4× 17 0.4× 45 401
Alessandro Agnoletti Italy 11 195 1.5× 36 0.5× 54 0.9× 52 1.2× 24 0.6× 17 318
Delphine Larrieu‐Ciron France 11 95 0.8× 70 0.9× 98 1.6× 28 0.6× 17 0.4× 21 364
Christian Plets Belgium 9 49 0.4× 137 1.8× 105 1.8× 25 0.6× 14 0.3× 14 435
Mary K. Gumerlock United States 9 160 1.3× 92 1.2× 158 2.6× 63 1.4× 20 0.5× 15 363
Martyn Carey United Kingdom 9 156 1.2× 23 0.3× 86 1.4× 74 1.7× 29 0.7× 23 327

Countries citing papers authored by Chiara Bosa

Since Specialization
Citations

This map shows the geographic impact of Chiara Bosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Bosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Bosa more than expected).

Fields of papers citing papers by Chiara Bosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Bosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Bosa. The network helps show where Chiara Bosa may publish in the future.

Co-authorship network of co-authors of Chiara Bosa

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Bosa. A scholar is included among the top collaborators of Chiara Bosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Bosa. Chiara Bosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Vercellino, Marco, et al.. (2023). Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study. Multiple Sclerosis Journal. 29(13). 1526–1539. 8 indexed citations
3.
Cavalla, Paola, Chiara Bosa, Maria Barbara Pasanisi, et al.. (2022). Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort. Neurological Sciences. 43(7). 4373–4380. 6 indexed citations
4.
Miele, Giuseppina, Gianmarco Abbadessa, Paola Cavalla, et al.. (2022). Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study. Multiple Sclerosis and Related Disorders. 68. 104395–104395. 6 indexed citations
5.
Vercellino, Marco, et al.. (2022). Impact of COVID-19 lockdown on progressive multiple sclerosis patients. Neurological Sciences. 43(5). 2943–2946. 7 indexed citations
6.
Abbadessa, Gianmarco, Giuseppina Miele, Paola Cavalla, et al.. (2021). CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab. International Journal of Environmental Research and Public Health. 18(15). 8163–8163. 15 indexed citations
7.
Mercanti, Stefania Federica De, et al.. (2021). Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series. Frontiers in Neurology. 12. 691616–691616.
8.
Vercellino, Marco, Silvia Grifoni, Chiara Bosa, et al.. (2021). Acute and chronic synaptic pathology in multiple sclerosis gray matter. Multiple Sclerosis Journal. 28(3). 369–382. 17 indexed citations
9.
Cavalla, Paola, Chiara Bosa, Maria Barbara Pasanisi, et al.. (2019). Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders. Journal of Neuroimmunology. 339. 577122–577122. 26 indexed citations
10.
Rudà, Roberta, Chiara Bosa, Michela Magistrello, et al.. (2015). Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study. Neuro-Oncology. 18(2). 261–268. 28 indexed citations
11.
Trevisan, Elisa, Luca Bertero, Chiara Bosa, et al.. (2014). Antiangiogenic therapy of brain tumors: the role of bevacizumab. Neurological Sciences. 35(4). 507–514. 11 indexed citations
12.
Simonetti, G., Elisa Trevisan, Antonio Silvani, et al.. (2013). Safety of bevacizumab in patients with malignant gliomas: a systematic review. Neurological Sciences. 35(1). 83–89. 17 indexed citations
13.
Rudà, Roberta, Luca Bertero, Elisa Trevisan, et al.. (2013). Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro-Oncology. 15(12). 1739–1749. 62 indexed citations
14.
Soffietti, Riccardo, Elisa Trevisan, Luca Bertero, Chiara Bosa, & Roberta Rudà. (2012). Anti-Angiogenic Approaches to Malignant Gliomas. Current Cancer Drug Targets. 12(3). 279–288. 15 indexed citations
15.
Soffietti, Riccardo, Elisa Trevisan, Chiara Bosa, Luca Bertero, & Roberta Rudà. (2012). Phase II trial of bevacizumab and fotemustine in recurrent grade III gliomas.. Journal of Clinical Oncology. 30(15_suppl). 2075–2075. 4 indexed citations
16.
Soffietti, Riccardo, Elisa Trevisan, Roberta Rudà, et al.. (2011). Phase II trial of bevacizumab with fotemustine in recurrent glioblastoma: Final results of a multicenter study of AINO (Italian Association of Neuro-oncology).. Journal of Clinical Oncology. 29(15_suppl). 2027–2027. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Ramos Breakdown of academic impact, for papers by Massimo Napolitano Breakdown of academic impact, for papers by Andrés Cervio Breakdown of academic impact, for papers by Christopher Dardis Breakdown of academic impact, for papers by Danielle Golub Breakdown of academic impact, for papers by Alessandro Agnoletti Breakdown of academic impact, for papers by Delphine Larrieu‐Ciron Breakdown of academic impact, for papers by Christian Plets Breakdown of academic impact, for papers by Mary K. Gumerlock Breakdown of academic impact, for papers by Martyn Carey
Rankless by CCL
2026